> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# European Medicines Agency
- URL: https://www.whiteroseintelligence.com/european-medicines-agency/
- Published: 1999-01-02T15:49:00.000Z
- Updated: 2025-10-14T18:59:55.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization

The **European Medicines Agency (EMA)** is a multination agency of the European Union in charge of the evaluation and supervision of medicinal products.

## History

The EMA contributed to the Global Vaccine Action Plan developed by the [Decade of Vaccines Collaboration](https://www.whiteroseintelligence.com/Decade-of-Vaccines-Collaboration), endorsed by the 194 Member States of the World Health Assembly in May 2012, and published on the [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization)'s website in February 2013.[\[1\]](#fn1)

### COVID-19

The EMA is a collaborator in the [Accelerating COVID-19 Therapeutic Interventions and Vaccines](https://www.whiteroseintelligence.com/Accelerating-COVID-19-Therapeutic-Interventions-and-Vaccines) (ACTIV) initiative.[\[2\]](#fn2)

While in the process of evaluating the [Pfizer–BioNTech COVID-19 vaccine](https://www.whiteroseintelligence.com/Pfizer-BioNTech-COVID-19-vaccine) (BNT162b2) in December 2020, the EMA suffered a cyberattack, resulting in the leak of classified regulatory documents to journalists, academics and the public via the dark web.[\[3\]](#fn3)[\[4\]](#fn4)[\[5\]](#fn5) The documents revealed internal concerns about low production quality in the mRNA vaccine candidate, and regulators' efforts to have [Pfizer](https://www.whiteroseintelligence.com/Pfizer) and [BioNTech](https://www.whiteroseintelligence.com/BioNTech) rectify these deficiencies.[\[6\]](#fn6)[\[7\]](#fn7)[\[8\]](#fn8) The EMA ultimately authorized the vaccine on December 21, 2020, satisfied that the product quality was "sufficiently consistent and acceptable."[\[9\]](#fn9)[\[10\]](#fn10)

Covid Truths published a number of these files in April 2021, including copies of the Rapporteur's Assessment Reports.[\[11\]](#fn11) On October 29, 2022, the [Canadian Covid Care Alliance](https://www.whiteroseintelligence.com/Canadian-Covid-Care-Alliance) (CCCA) published a paper authored by [Maria Gutschi](https://www.whiteroseintelligence.com/Maria-Gutschi) based on the leaked EMA documents analyzing the manufacturing and quality issues underlying BNT162b2.[\[12\]](#fn12) A video presentation of the investigation was also published to BitChute and the CCCA website.[\[13\]](#fn13)[\[14\]](#fn14)

## Organization

The EMA is a member of the Joint Coordination Group of the [Coalition for Epidemic Preparedness Innovations](https://www.whiteroseintelligence.com/Coalition-for-Epidemic-Preparedness-Innovations) (CEPI),[\[15\]](#fn15) a benefactor-level member of Health Level Seven International (HL7),[\[16\]](#fn16) as well as a member of the International Council for Harmonisation (ICH)[\[17\]](#fn17) and the International Pharmaceutical Regulators Programme.[\[18\]](#fn18) It is also a partner of the Society for Immunotherapy of Cancer[\[19\]](#fn19) and the Vaccine Confidence Project.[\[20\]](#fn20)

### Personnel

| Name           | Position                                                               | Notes                                 |
| -------------- | ---------------------------------------------------------------------- | ------------------------------------- |
| Marco Cavaleri | Head of Biological Health Threats and Vaccines Strategy[\[21\]](#fn21) | Chair of the EMA's COVID-19 Taskforce |

## Publications

- March 27, 2025: "[Guideline on the quality aspects of mRNA vaccines (Draft)](https://web.archive.org/web/20251014185148/https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-quality-aspects-mrna-vaccines%5Fen.pdf)"

## External links

- [Campfire Wiki](https://www.campfire.wiki/doku.php?id=european%5Fmedicines%5Fagency)
- [Twitter](https://twitter.com/EMA%5FNews)
- [Wikipedia](https://en.wikipedia.org/wiki/European%5FMedicines%5FAgency)
- [Wikispooks](https://wikispooks.com/wiki/European%5FMedicines%5FAgency)

---

1. *Annex 5: Countries and Organizations that Contributed to the Elaboration of the GVAP.* World Health Organization. Retrieved June 3, 2023, from <https://web.archive.org/web/20230603045157/https://cdn.who.int/media/docs/default-source/vaccines-and-immunization/gvap-annex5.pdf?sfvrsn=f3aa55e3%5F2> [↩︎](#fnref1)
2. *ACTIV.* National Institutes of Health (NIH). Retrieved April 1, 2022, from <http://archive.today/2022.01.11-042823/https://www.nih.gov/research-training/medical-research-initiatives/activ> [↩︎](#fnref2)
3. Stubbs, J. (2020, December 9). *Hackers steal Pfizer/BioNTech COVID-19 vaccine data in Europe, companies say.* Reuters. <https://web.archive.org/web/20230916173447/https://www.reuters.com/article/us-ema-cyber-idUKKBN28J2Q7> [↩︎](#fnref3)
4. Glanville, D. (2021, January 15). *Cyberattack on EMA - update 5.* European Medicines Agency. <https://web.archive.org/web/20230916173203/https://www.ema.europa.eu/en/news/cyberattack-ema-update-5> [↩︎](#fnref4)
5. *Statement on EMA Cyberattack.* (2020, December 9). Pfizer. <https://web.archive.org/web/20230916173702/https://www.pfizer.com/news/announcements/statement-ema-cyberattack> [↩︎](#fnref5)
6. Tinari, S. (2021). *The EMA covid-19 data leak, and what it tells us about mRNA instability.* BMJ, n627\. <https://doi.org/10.1136/bmj.n627> [↩︎](#fnref6)
7. Abbasi, J. (2021). *Data Leak Exposes Early COVID-19 Vaccine Manufacturing Hiccups.* JAMA, 325(14), 1385\. <https://doi.org/10.1001/jama.2021.5002> [↩︎](#fnref7)
8. Lovett, S. (2021, March 11). *European regulator raised concern over quality of early Pfizer vaccine batches, leaked emails show.* The Independent. <https://web.archive.org/web/20230916174105/https://www.independent.co.uk/news/science/covid-pfizer-vaccine-doses-uk-latest-b1815398.html> [↩︎](#fnref8)
9. Committee for Medicinal Products for Human Use (CHMP). (2021, February 19). *European public assessment report (EPAR) - Comirnaty, INN-COVID-19 mRNA Vaccine (nucleoside-modified).* European Medicines Agency. <https://web.archive.org/web/20230912122645/https://www.ema.europa.eu/en/documents/assessment-report/comirnaty-epar-public-assessment-report%5Fen.pdf> [↩︎](#fnref9)
10. Kansteiner, F. (2021, March 15). *Pfizer’s COVID-19 vaccine faced EMA manufacturing concerns ahead of emergency nod: report.* Fierce Pharma. <https://web.archive.org/web/20230710140521/https://www.fiercepharma.com/manufacturing/pfizer-s-covid-19-vaccine-subject-to-ema-manufacturing-concerns-ahead-december> [↩︎](#fnref10)
11. *EMA Leaked Papers.* (2021, April 17). Covid Truths. <https://web.archive.org/web/20221110200241/https://www.covidtruths.co.uk/2021/04/ema-leaked-papers/> [↩︎](#fnref11)
12. Gutschi, L. M., Speicher, D. J., Natsheh, S., Oldfield, P., Britz-Mckibbon, P., Palmer, M., Karrow, N., Massie, B., Mallard, B., Chan, G., & Pelech, S. (2022). *An Independent Analysis of the Manufacturing and Quality Issues of the BNT162b BioNTech/Pfizer Quasi-vaccine based on the European Medicines Agency’s Public Assessment Report (EPAR).* Canadian Covid Care Alliance. <https://web.archive.org/web/20221110200231/https://www.canadiancovidcarealliance.org/wp-content/uploads/2022/11/22OC29%5FEMA-Analysis-of-BNT162b-Manufacture.pdf> [↩︎](#fnref12)
13. DRWR2021\. (2022, November 2). *Quality issues with mRNA Covid vaccine production.* BitChute. <https://www.bitchute.com/video/muB0nrznCAC4/>. Archived version available at <http://archive.today/2022.11.08-112519/https://www.bitchute.com/video/muB0nrznCAC4/> [↩︎](#fnref13)
14. *An Independent Analysis of the Manufacturing and Quality Issues of the BNT162b BioNTech/Pfizer Vaccine (Video).* Canadian Covid Care Alliance. Retrieved November 9, 2022, from <https://web.archive.org/web/20221109043439/https://www.canadiancovidcarealliance.org/media-resources/an-independent-analysis-of-the-manufacturing-and-quality-issues-of-the-bnt162b-biontech-pfizer-vaccine-video/> [↩︎](#fnref14)
15. *Who we are.* CEPI. Retrieved October 19, 2022, from <https://web.archive.org/web/20221019165747/https://cepi.net/about/whoweare/> [↩︎](#fnref15)
16. *Benefactors of Health Level Seven.* HL7 International. Retrieved June 1, 2023, from <https://web.archive.org/web/20230601080537/http://www.hl7.org/about/benefactors.cfm> [↩︎](#fnref16)
17. *Members & Observers.* International Council for Harmonisation. Accessed April 24, 2022, from <http://archive.today/2022.04.24-053337/https://www.ich.org/page/members-observers> [↩︎](#fnref17)
18. *Members & Observers.* International Pharmaceutical Regulators Programme. Retrieved April 23, 2022, from <http://archive.today/2022.04.24-064614/https://www.iprp.global/members> [↩︎](#fnref18)
19. *Cancer Immunotherapy Partnerships and Collaborations.* Society for Immunotherapy of Cancer. Retrieved March 27, 2023, from <https://web.archive.org/web/20230327191240/https://www.sitcancer.org/aboutsitc/partnerships#champions> [↩︎](#fnref19)
20. *Partnerships.* The Vaccine Confidence Project. Retrieved April 28, 2022, from <https://web.archive.org/web/20220428122506/https://www.vaccineconfidence.org/partners-funders> [↩︎](#fnref20)
21. Kouassi, V. *Marco Cavaleri.* REVIVE. Retrieved March 8, 2023, from <https://web.archive.org/web/20230308225834/https://revive.gardp.org/marco-cavaleri/> [↩︎](#fnref21)